29. October, 2024
Company presentation Nordnet – follow up
In case you did not have time to watch the online Nordnet company presentation,...
16. October, 2024
Halfway milestone patient recruitment in Paediatric Study 0202
Cessatech announces that recruitment has today reached the halfway point for patient recruitment with...
26. August, 2024
Cessatech and Proveca announce world-wide excluding US commercial partnership for CT001
Cessatech and Proveca enter an exclusive agreement for the commercialization of CT001 world-wide excluding...
12. August, 2024
Cessatech extends Loan Facility Agreement to DKK 10 million…
Cessatech extends its undrawn Loan Facility Agreement to DKK 10 million to support the...
5. July, 2024
Anders Dyhr Dombernowsky-Toft appointed to the Board of Directors
Cessatech has today appointed Anders Dyhr Dombernowsky-Toft to the Board of Directors at the...
28. June, 2024
New data on paediatric pain relief at the PAGE conference in Rome favouring its lead candidate CT001
On 28 June – Cessatech A/S (“Cessatech” or “the Company”) announces that the presentation...
3. June, 2024
Cessatech announces superior simulated pain efficacy in children
Cessatech announces the final simulated efficacy data in children with CT001 from the abstract...
27. May, 2024
Cessatech reports first patient dosed in final Safety Study 0202 of lead product candidate CT001
Cessatech A/S announces that the Safety Study 0202 has now been initiated with dosing...
18. March, 2024
Acute pain treatment – large unmet need, paediatrics receive least…mainly due to inadequate solutions
More than 20 million children annually, alone in Europe, are subject to acute pain...
29. February, 2024
Annual Report 2023
Cessatech A/S publishes its annual report for the fiscal year 2023, which also includes...
12. February, 2024
Treating children is not just like treating small adults
Giving medicine to children can’t be a one-size-fits-all approach. Their changing anatomy and...
9. January, 2024
Cessatech 2024 major milestones and focus
Now is the time – 2024 will be an extremely busy and hopefully exciting...